Anti-inflammatory and immunosuppressive drugs and reproduction. Academic Article uri icon

Overview

abstract

  • Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus workshop of international experts discussing effects of anti-inflammatory, immunosuppressive and biological drugs during pregnancy and lactation. In addition, effects of these drugs on male and female fertility and possible long-term effects on infants exposed to drugs antenatally are discussed where data were available. Recommendations for drug treatment during pregnancy and lactation are given.

authors

  • Ă˜stensen, Monika
  • Khamashta, Munther
  • Lockshin, Michael D
  • Parke, Ann
  • Brucato, Antonio
  • Carp, Howard
  • Doria, Andrea
  • Rai, Raj
  • Meroni, Pierluigi
  • Cetin, Irene
  • Derksen, Ronald
  • Branch, Ware
  • Motta, Mario
  • Gordon, Caroline
  • Ruiz-Irastorza, Guillermo
  • Spinillo, Arsenio
  • Friedman, Deborah
  • Cimaz, Rolando
  • Czeizel, Andrew
  • Piette, Jean Charles
  • Cervera, Ricard
  • Levy, Roger A
  • Clementi, Maurizio
  • De Carolis, Sara
  • Petri, Michelle
  • Shoenfeld, Yehuda
  • Faden, David
  • Valesini, Guido
  • Tincani, Angela

publication date

  • May 11, 2006

Research

keywords

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Pregnancy Complications
  • Reproduction

Identity

PubMed Central ID

  • PMC1526635

Scopus Document Identifier

  • 33745243801

Digital Object Identifier (DOI)

  • 10.1097/01.MIB.0000164023.10848.c4

PubMed ID

  • 16712713

Additional Document Info

volume

  • 8

issue

  • 3